Use of antiplatelet thrombolysin in the preparation of medicine for treating thrombotic thrombocytopenic purpura

• 收藏
• 分享

专利权人:

Zhaoke Pharmaceutical (Hefei) Company Limited

发明人:

Li, Xiaoyi,Dai, Xiangrong

申请号：

AU2016399395

公开号：

AU2016399395A1

申请日:

2016.04.22

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Disclosed is the use of an antiplatelet thrombolysin in the preparation of a medicine for treating thrombotic thrombocytopenic purpura (TTP). The main pathogenesis of TTP is a von Willebrand factor-cleaving protease, namely, a congenital defect in ADAMTS13 expression or inhibition of ADAMTS13 expression by an autoantibody, thereby resulting in the aggregation of a large number of von Willebrand factors (vWFs)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/